Abstract
Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.
| Original language | English |
|---|---|
| Pages (from-to) | 165-171 |
| Number of pages | 7 |
| Journal | Journal of Affective Disorders |
| Volume | 219 |
| DOIs | |
| Publication status | Published - Sep 1 2017 |
Fingerprint
Keywords
- Bipolar disorder
- Current anxiety symptoms
- Depression
- Lifetime anxiety disorder
- Longitudinal
ASJC Scopus subject areas
- Clinical Psychology
- Psychiatry and Mental health
Cite this
Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. / Shah, Saloni; Kim, Jane P.; Park, Dong Yeon; Kim, Hyun; Yuen, Laura D.; Do, Dennis; Dell'Osso, Bernardo; Hooshmand, Farnaz; Miller, Shefali; Wang, Po W.; Ketter, Terence A.
In: Journal of Affective Disorders, Vol. 219, 01.09.2017, p. 165-171.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder
AU - Shah, Saloni
AU - Kim, Jane P.
AU - Park, Dong Yeon
AU - Kim, Hyun
AU - Yuen, Laura D.
AU - Do, Dennis
AU - Dell'Osso, Bernardo
AU - Hooshmand, Farnaz
AU - Miller, Shefali
AU - Wang, Po W.
AU - Ketter, Terence A.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.
AB - Aims To assess differential relationships between lifetime anxiety disorder/current anxiety symptoms and longitudinal depressive severity in bipolar disorder (BD). Methods Stanford BD Clinic outpatients enrolled during 2000–2011 were assessed with the Systematic Treatment Enhancement Program for BD (STEP-BD) Affective Disorders Evaluation and followed with the STEP-BD Clinical Monitoring Form while receiving naturalistic treatment for up to two years. Baseline unfavorable illness characteristics/current mood symptoms and times to depressive recurrence/recovery were compared in patients with versus without lifetime anxiety disorder/current anxiety symptoms. Results Among 105 currently recovered patients, lifetime anxiety disorder was significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics, hastened depressive recurrence (driven by earlier onset age), and a significantly (> two-fold) higher Kaplan-Meier estimated depressive recurrence rate, whereas current anxiety symptoms were significantly associated with 10/27 (37.0%) demographic/other unfavorable illness characteristics/current mood symptoms/current psychotropics and hastened depressive recurrence (driven by lifetime anxiety disorder), but only a numerically higher Kaplan-Meier estimated depressive recurrence rate. In contrast, among 153 currently depressed patients, lifetime anxiety disorder/current anxiety symptoms were not significantly associated with time to depressive recovery or depressive recovery rate. Limitations American tertiary BD clinic referral sample, open naturalistic treatment. Conclusions Research is needed regarding differential relationships between lifetime anxiety disorder and current anxiety symptoms and hastened/delayed depressive recurrence/recovery – specifically whether lifetime anxiety disorder versus current anxiety symptoms has marginally more robust association with hastened depressive recurrence, and whether both have marginally more robust associations with hastened depressive recurrence versus delayed depressive recovery, and related clinical implications.
KW - Bipolar disorder
KW - Current anxiety symptoms
KW - Depression
KW - Lifetime anxiety disorder
KW - Longitudinal
UR - http://www.scopus.com/inward/record.url?scp=85019723926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019723926&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2017.05.007
DO - 10.1016/j.jad.2017.05.007
M3 - Article
AN - SCOPUS:85019723926
VL - 219
SP - 165
EP - 171
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
SN - 0165-0327
ER -